【投融资动态】Synaire新奈Pre-A轮融资，融资额数千万人民币，投资方为水木创投、华盖资本等

Group 1 - The core viewpoint of the article highlights that Hefei Xinnai Medical Technology Co., Ltd. has successfully completed a Pre-A round of financing, raising several tens of millions of RMB, with participation from investors such as Waterwood Venture Capital, Huagai Capital, and Baohe Venture Capital [1] - Hefei Xinnai Medical Technology Co., Ltd. focuses on the research and development of intelligent respiratory therapy devices, aiming to penetrate the mid-to-high-end market dominated by brands like ResMed through a strategy of "high-end performance + mid-range pricing" [1] - The company initiates its market entry with a B2B approach targeting hospitals, pharmacies, and insurance companies, while gradually expanding into the consumer market with a B2C strategy, establishing a brand evolution path of "professional first, then consumer" [1]